Lifecore Biomedical Inc (LFCR) Directors and Executive Officers

John D. Morberg
Executive Vice-President, Chief Financial Officer and Secretary - (Principal Financial Officer and Principal Accounting Officer)

Raymond Diradoorian
Director -

Katrina L. Houde
Director -

Paul H. Johnson
Director -

Christopher Kiper
Director -

BDO USA, P.C.
We have served as the Company s auditor - since

Humberto C. Antunes
Director -

Matthew Korenberg
Director -

Paul Josephs
President and Chief Executive Officer - (Principal Executive Officer) and Director

Jeffrey L. Edwards
Director -

Jason Aryeh
Director -

Joshua E. Schechter
Director -

Nelson Obus
Director -,

Lifecore Biomedical Inc currently has 209 employees.

News about Lifecore Biomedical Inc Key Personnel

Lifecore Biomedical Strengthens Operations and Financial Health with Key Appointment and $24.3 Million Capital Raise,

Lifecore Biomedical Enhances Its Operational Foundation with Strategic Leadership Appointment and Capital InfusionIn a series of strategic maneuvers aimed at bolstering its operational capabilities and financial standing, Lifecore Biomedical Inc. has taken significant steps to navigate a challenging landscape within the life sciences sector. Recently, the company appointed Thomas Guldager as its new Vice President of Operations, coupled with a successful Private Investment in Public Equity (PIPE) transaction that raised $24.3 million. These developments illustrate Lifecore’s commitment to not only weathering current financial challenges but also positioning itself for future growth. Leadership Enhancement...

Navigating Legal Challenges and Achieving Record ROE: Lifecore Biomedical Strives for Success amidst Shareholder Turbulence,

Title for the Objective of the Navigating Legal Challenges: Lifecore Biomedical Faces Shareholder Turbulence and High ROE in Q4 2024

In a recent development, Lifecore Biomedical Inc announced the appointment of Brikkelle Thompson as the Senior Vice President of Human Resources. With nearly 25 years of experience driving top-performing cultures and building exceptional teams, Thompson s addition to the leadership team is expected to further enhance the company s human resource strategies and contribute to its continued success.
Meanwhile, Lifecore Biomedical Inc achieved a remarkable return on equity (ROE) of 284.97% in the fourth quarter of 2024, reaching a new high for the company. This except...

Lifecore Biomedical's Tactical Amendments with Lenders Secure $8 Million Non-Dilutive Liquidity, Drives Growth and Innovation

Lifecore Biomedical Secures $8 Million in Non-Dilutive, Incremental Liquidity through Lender Amendments
In a recent move, Lifecore Biomedical, a leading medical device company, has successfully executed a series of incremental liquidity initiatives, resulting in approximately $8 million of much-needed funding. These initiatives, accomplished through various amendments with lenders, provide the company with essential non-dilutive capital to fuel its growth and innovation efforts.
The financing landscape for biomedical companies can be particularly challenging, with traditional sources of funding often falling short in meeting the unique demands of the industry. Lifecore Biomedical, mindful of these ch...

Lifecore Biomedical Faces Financial Challenges but Demonstrates Resilience in the Pharmaceutical Industry

Lifecore Biomedical, Inc. (NASDAQ: LFCR), a leading contract development and manufacturing organization (CDMO) in the pharmaceutical industry, recently provided a business update that indicates turbulent times for the company. Their shares experienced a significant decline of -8.41%, while a cumulative net loss of -$65 million was recorded during the 12-month period ending in the third quarter of 2023. As a result, Lifecore Biomedical reported a negative return on equity (ROE) of -87.45%.
These figures raise concerns as investors evaluate the performance of the Chaska-based biotech company. The unexpected downturn in stock value and substantial financial losses, though alarming, should be considered...

Lifecore Biomedical Inc

Officers & Directors

News about Lifecore Biomedical Inc Key Personnel

Lifecore Biomedical Strengthens Operations and Financial Health with Key Appointment and $24.3 Million Capital Raise,

Navigating Legal Challenges and Achieving Record ROE: Lifecore Biomedical Strives for Success amidst Shareholder Turbulence,

Lifecore Biomedical's Tactical Amendments with Lenders Secure $8 Million Non-Dilutive Liquidity, Drives Growth and Innovation

Lifecore Biomedical Faces Financial Challenges but Demonstrates Resilience in the Pharmaceutical Industry